Copyright Reports & Markets. All rights reserved.

Global Interleukin 12 Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Interleukin 12 Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Interleukin 12 Receptor Market Size Growth Rate by Product
      • 1.4.2 Edodekin Alfa SR
      • 1.4.3 M-9241
      • 1.4.4 LY-3232094
      • 1.4.5 NMIL-121
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Interleukin 12 Receptor Market Size Growth Rate by End User
      • 1.5.2 In-Patient
      • 1.5.3 Out-Patient
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Interleukin 12 Receptor Market Size
      • 2.1.1 Global Interleukin 12 Receptor Revenue 2014-2025
      • 2.1.2 Global Interleukin 12 Receptor Sales 2014-2025
    • 2.2 Interleukin 12 Receptor Growth Rate by Regions
      • 2.2.1 Global Interleukin 12 Receptor Sales by Regions
      • 2.2.2 Global Interleukin 12 Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Interleukin 12 Receptor Sales by Manufacturers
      • 3.1.1 Interleukin 12 Receptor Sales by Manufacturers
      • 3.1.2 Interleukin 12 Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Interleukin 12 Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Interleukin 12 Receptor Revenue by Manufacturers
      • 3.2.1 Interleukin 12 Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Interleukin 12 Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Interleukin 12 Receptor Price by Manufacturers
    • 3.4 Interleukin 12 Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Interleukin 12 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Interleukin 12 Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Interleukin 12 Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Interleukin 12 Receptor Sales by Product
    • 4.2 Global Interleukin 12 Receptor Revenue by Product
    • 4.3 Interleukin 12 Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Interleukin 12 Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Interleukin 12 Receptor by Countries
      • 6.1.1 North America Interleukin 12 Receptor Sales by Countries
      • 6.1.2 North America Interleukin 12 Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Interleukin 12 Receptor by Product
    • 6.3 North America Interleukin 12 Receptor by End User

    7 Europe

    • 7.1 Europe Interleukin 12 Receptor by Countries
      • 7.1.1 Europe Interleukin 12 Receptor Sales by Countries
      • 7.1.2 Europe Interleukin 12 Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Interleukin 12 Receptor by Product
    • 7.3 Europe Interleukin 12 Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Interleukin 12 Receptor by Countries
      • 8.1.1 Asia Pacific Interleukin 12 Receptor Sales by Countries
      • 8.1.2 Asia Pacific Interleukin 12 Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Interleukin 12 Receptor by Product
    • 8.3 Asia Pacific Interleukin 12 Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Interleukin 12 Receptor by Countries
      • 9.1.1 Central & South America Interleukin 12 Receptor Sales by Countries
      • 9.1.2 Central & South America Interleukin 12 Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Interleukin 12 Receptor by Product
    • 9.3 Central & South America Interleukin 12 Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Interleukin 12 Receptor by Countries
      • 10.1.1 Middle East and Africa Interleukin 12 Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Interleukin 12 Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Interleukin 12 Receptor by Product
    • 10.3 Middle East and Africa Interleukin 12 Receptor by End User

    11 Company Profiles

    • 11.1 Eli Lilly and Company
      • 11.1.1 Eli Lilly and Company Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Eli Lilly and Company Interleukin 12 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Eli Lilly and Company Interleukin 12 Receptor Products Offered
      • 11.1.5 Eli Lilly and Company Recent Development
    • 11.2 Mallinckrodt Plc
      • 11.2.1 Mallinckrodt Plc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Mallinckrodt Plc Interleukin 12 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Mallinckrodt Plc Interleukin 12 Receptor Products Offered
      • 11.2.5 Mallinckrodt Plc Recent Development
    • 11.3 Merck KGaA
      • 11.3.1 Merck KGaA Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck KGaA Interleukin 12 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck KGaA Interleukin 12 Receptor Products Offered
      • 11.3.5 Merck KGaA Recent Development
    • 11.4 Neumedicines Inc
      • 11.4.1 Neumedicines Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Neumedicines Inc Interleukin 12 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Neumedicines Inc Interleukin 12 Receptor Products Offered
      • 11.4.5 Neumedicines Inc Recent Development

    12 Future Forecast

    • 12.1 Interleukin 12 Receptor Market Forecast by Regions
      • 12.1.1 Global Interleukin 12 Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Interleukin 12 Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Interleukin 12 Receptor Market Forecast by Product
      • 12.2.1 Global Interleukin 12 Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Interleukin 12 Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Interleukin 12 Receptor Market Forecast by End User
    • 12.4 North America Interleukin 12 Receptor Forecast
    • 12.5 Europe Interleukin 12 Receptor Forecast
    • 12.6 Asia Pacific Interleukin 12 Receptor Forecast
    • 12.7 Central & South America Interleukin 12 Receptor Forecast
    • 12.8 Middle East and Africa Interleukin 12 Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Interleukin 12 Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Interleukin 12 Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Interleukin 12 Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Interleukin 12 Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Interleukin 12 Receptor in these regions.
      This research report categorizes the global Interleukin 12 Receptor market by top players/brands, region, type and end user. This report also studies the global Interleukin 12 Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Eli Lilly and Company
      Mallinckrodt Plc
      Merck KGaA
      Neumedicines Inc

      Market size by Product
      Edodekin Alfa SR
      M-9241
      LY-3232094
      NMIL-121
      Others
      Market size by End User
      In-Patient
      Out-Patient

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Interleukin 12 Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Interleukin 12 Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Interleukin 12 Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Interleukin 12 Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Interleukin 12 Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Interleukin 12 Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now